And while Musk’s body is in the spotlight now, it’s not the first time he’s admitted to using GLP-1 agonists to manage his weight. In October 2022, he was asked on X what his “secret” to ...

What’s the ongoing story: In a first, scientists at the World Health Organisation (WHO) have endorsed a new class of medicines known as GLP-1 receptor agonists, which mimic a hormone that regulates ...

For people with obesity or type 2 diabetes, glucagon-like peptide 1 (GLP-1) agonists (including Mounjaro, Wegovy, and Ozempic) have been labeled miracle drugs. But they aren’t miraculous for ...

GLP-1 receptor agonists emerge as promising therapies for MASLD, addressing metabolic dysfunction and offering potential improvements in liver health and fibrosis management. Study: Current Status ...

After many years of failed attempts to support them in losing weight and optimising their health through lifestyle intervention programmes, glucagon-like peptide-1 (GLP-1) receptor agonists are being ...

Glucagon-like peptide-1 (GLP-1) receptor agonists have quickly become some of the most ubiquitous drugs in the United States. Though they were originally indicated to treat diabetes, and to assist ...

Hilton is a leading global hospitality company with a portfolio of 24 world-class brands comprising more than 8,300 properties and over 1.25 million rooms, in 138 countries and territories.